Loading fund overlap…
2 of 73 unique stocks in common · Jaccard: 2.7%
A weighted portfolio overlap of 3.42% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹3.42 is allocated to the exact same companies at the same relative proportions. The schemes share 2 common holdings.
The largest overlapping asset in their portfolios is Divi's Laboratories, which commands a weight of 2.62% in SBI Equity Hybrid Fund and 6.57% in SBI Healthcare Opportunities Fund. Holding both schemes increases your concentration in Divi's Laboratories rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in SBI Equity | in SBI Healthcare |
|---|---|---|
| Divi's LaboratoriesPharmaceuticals & Biotechnology | 2.62% | 6.57% |
| Max Healthcare InstituteHealthcare Services | 0.80% | 4.76% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.